Contact

Email:  contact@usapeptidesciences.net

Phone: (801) 855-6987

Address: 5312 W Shaggy Peak Dr, Riverton, UT. 84096

Research and Development of peptides have been ongoing for a hundred years and this field shows no signs of slowing down. We, at USA Peptide Sciences appreciate the demand for more research and provide resources to help in that development. In regards to understanding peptides and a history overview, the following section will address this information.

Peptides are short chains of amino acids (the building blocks of protein). 

• Analogy: Think of a peptide like a text message sent to a cell. The sequence of amino acids (the text) tells the cell exactly what to do, like produce more growth hormone or regulate blood sugar.
• Chemical Formula: Peptides are bound by chemical bonds called amide or peptide bonds. In scientific notation, the formation of a peptide bond releases a water molecule: Amino Acid + Amino Acid → Peptide + H₂O.

The first major peptides developed for human use primarily originated as life-saving metabolic, hormonal, and endocrine treatments. Unlike modern wellness or “research” compounds, these are FDA-approved pharmaceuticals. They include sermorelin (a synthetic GHRH) and nine other foundational peptide drugs. 

The First 10 Major FDA-Approved Peptide Drugs

1. Insulin (1922): The world’s first peptide drug. It is a protein hormone of 51 amino acids used to manage blood sugar in Type 1 and Type 2 diabetes. 
2. Oxytocin (1954): The first fully synthesized peptide hormone. In the body, it stimulates the uterus during childbirth and aids in lactation, 
3. Vasopressin (1957): Synthesized alongside oxytocin. It regulates water retention in the kidneys and is used to treat severe low blood pressure. 
4. Calcitonin (1970): An endogenous (made in the body) hormone used to treat bone loss, high blood calcium levels, and Paget’s disease. 
5. Somatostatin (1979): Used to regulate the secretion of growth hormone and insulin, often to treat specific rare hormone-producing tumors. 
6. Leuprolide (1985): A synthetic analog of Gonadotropin-Releasing Hormone (GnRH). It is used to treat hormone-dependent cancers (like prostate cancer) and endometriosis. 
7. Octreotide (1988): An engineered version of somatostatin used to treat acromegaly (excess growth hormone) and severe diarrhea. 
8. Sermorelin (1990): A synthetic analog of Growth Hormone-Releasing Hormone (GHRH). It was historically used to diagnose and treat growth hormone deficiencies in children. 
9. Desmopressin (1978/1990s): A modified version of vasopressin. It treats diabetes insipidus (frequent urination/thirst) and bedwetting. [1]
10. Goserelin (1989): Another GnRH agonist used to suppress the production of sex hormones for the management of breast and prostate cancers. 

(Note: While insulin was the first, drug development rapidly evolved to include many other amino-acid chains over the decades. To learn more about modern classifications, you can check out the Research Peptide Comparison Chart or the National Institutes of Health breakdown of peptide hormone development). – Powered by AI

Understanding Peptide Science and it’s implications is paramount in the future of medicine. 

We operate out of Riverton Utah and ship only within US borders. If you have further questions, please contact us. See our contact page for further information.